The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level.

Authors	Erol Erduran, Aysenur Bahadir
Journal	Pediatric hematology and oncology (Pediatr Hematol Oncol) Vol. 28 Issue 8 Pg. 721-2 (Nov 2011) ISSN: 1521-0669 [Electronic] England
PMID	21875319 (Publication Type: Case Reports, Letter)
Chemical References	Recombinant Proteins Erythropoietin
Topics	Anemia, Neonatal (blood, etiology, therapy) Blood Transfusion, Intrauterine Erythropoietin (blood, therapeutic use) Humans Infant, Newborn Male Recombinant Proteins (blood, therapeutic use) Rh Isoimmunization (blood, complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!